Long-term Safety and Effectiveness of Growtropin®-II Treatment in Children With Short Stature
Key facts
- Who runs it
- Dong-A ST Co., Ltd.
- Where
- South Korea1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 5,000 people, planned
- Started
- 8 Feb 2021
- Expected to end
- Feb 2035
- Type of study
- Observational
- Record updated
- 21 July 2026
Who can take part
The trial is looking for children with short stature who are treated with Growtropin®-II. It follows how safe and effective this growth hormone is over a long time.
- Age
- 2 Years and older
- Sex
- All
- Disease stage
- Short stature caused by growth hormone deficiency (GHD), idiopathic short stature (ISS, short stature with no known cause), Turner syndrome (TS) or being born small for gestational age (SGA).
- Main reasons for not taking part
- Children whose growth plates in the bones have closed (epiphyseal closure)
- Children without an official height record from at least 6 months before
Show the full registry criteria (3)Hide the full registry criteria
Who can take part
- Children with short stature by growth hormone deficiency(GHD) or idiopathic short stature (ISS) or turner's syndrome(TS) or small for gestational age(SGA)
- Children who has official height record at least 6 months prior
Who cannot take part
- Children with Epiphyseal closure
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
This trial is currently available in South Korea.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study evaluates long-term safety and effectiveness of Growtropin®-II treatment in children with short stature.
The group in the trial
- Growth hormone
Growtropin®-II
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 1 eligibility question with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Open, Multi-center, Non-interventional, Prospective/ Retrospective Observational Study on Long-term Safety and Effectiveness of Growtropin®-II Treatment in Children With Short Stature
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Criteria questions
- Built from NCT04798690, who can take part
- Record updated
- 21 July 2026